DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Netazepide is an investigational drug.
There have been 6 clinical trials for Netazepide. The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2011.
The most common disease conditions in clinical trials are Carcinoid Tumor, Gastritis, and Atrophy. The leading clinical trial sponsors are Trio Medicines Ltd., Royal Liverpool University Hospital, and Julian A Abrams, MD.
Recent Clinical Trials for Netazepide
|YF476 in Barrett's Esophagus||Columbia University||Phase 2|
|YF476 in Barrett's Esophagus||University of Cambridge||Phase 2|
|YF476 in Barrett's Esophagus||Trio Medicines Ltd.||Phase 2|